Experience of using transvaginal sclerotherapy in the treatment of ovarian endometriomas

Abstract

BACKGROUND: Ethanol sclerotherapy is an effective and a safe surgical treatment method for ovarian endometrioma (OMA). Destruction with 95% ethanol solution of the capsule allows minimal impact on the ovarian reserve. However, this method should be thoroughly evaluated for the possibility to be used more frequently in practice.

AIM: To determine the indications for the use of transvaginal sclerotherapy in surgical treatment of OMA.

MATERIAL AND METHODS: Between October 2021 and October 2023, 17 patients with OMA were operated at the Moscow Regional Research Institute of Obstetrics and Gynecology, with sclerotherapy performed by transvaginal access. Clinical manifestations included pelvic pain (76.4%), dysmenorrhea (82.3%), dyspareunia (47.0%), bowel symptoms (35.3%), polymenorrhea (47.0%), and infertility (64.7%). Eleven (64.7%) of the patients had been previously operated because of ОМА.

RESULTS: Postoperative anti-Mullerian hormone (AMH) levels were slightly reduced (mean difference before and after the surgery was 0.47 ng/ml). The mean antral follicle count in the both ovaries were 10.8 before surgery and 8.6 after surgery. The volume of the ovary decreased from 2 to 6 times after sclerotherapy of the endometrioma. Symptoms recurred in four women. Six (35.2%) recurrences of endometrioma were noted with ultrasound control after 3, 6, and 12 months postoperatively. Endometrioid detritus in the cyst capsule was not detected in 64.8% of cases.

CONCLUSION: Preliminary results indicates the use of sclerotherapy by transvaginal access with ultrasound control for the treatment of endometriomas in women of reproductive age and patients planning pregnancy by ART with any level of ovarian reserve and recurrent, previously histologically confirmed, symptomatic endometriomas in women of reproductive age with no plans for pregnancy presently with a reduced ovarian reserve (AMH <1.2 ng/ml) and with any level of ovarian reserve but with symptomatic endometrioma in the preserved ovary. Transvaginal access is applicable for symptomatic endometriomas in women who had undergone several operations in the past.

Keywords

endometrioma / infertility / surgical treatment of endometriomas / assisted reproductive technology

References

[1] Chen Y, Pei H, Chang Y, et al. The impact of endometrioma and laparoscopic cystectomy on ovarian reserve and the exploration of related factors assessed by serum anti-Mullerian hormone: a prospective cohort study. J Ovarian Res. 2014;7:108. doi: 10.1186/s13048-014-0108-0

[2] Chen Y., Pei H., Chang Y., et al. The impact of endometrioma and laparoscopic cystectomy on ovarian reserve and the exploration of related factors assessed by serum anti-Mullerian hormone: a prospective cohort study // J Ovarian Res. 2014. Vol. 7. P. 108. doi: 10.1186/s13048-014-0108-0

[3] Chen Y, Pei H, Chang Y, et al. The impact of endometrioma and laparoscopic cystectomy on ovarian reserve and the exploration of related factors assessed by serum anti-Mullerian hormone: a prospective cohort study. J Ovarian Res. 2014;7:108. doi: 10.1186/s13048-014-0108-0

[4] Hughesdon PE. The structure of endometrial cysts of the ovary. J Obstet Gynaecol Br Emp. 1957;64(4):481–487. doi: 10.1111/j.1471-0528.1957.tb06276.x

[5] Hughesdon P.E. The structure of endometrial cysts of the ovary // J Obstet Gynaecol Br Emp. 1957. Vol. 64, N 4. P. 481–487. doi: 10.1111/j.1471-0528.1957.tb06276.x

[6] Hughesdon PE. The structure of endometrial cysts of the ovary. J Obstet Gynaecol Br Emp. 1957;64(4):481–487. doi: 10.1111/j.1471-0528.1957.tb06276.x

[7] Hachisuga T, Kawarabayashi T. Histopathological analysis of laparoscopically treated ovarian endometriotic cysts with special reference to loss of follicles. Hum Reprod. 2002;17(2):432–435. doi: 10.1093/humrep/17.2.432

[8] Hachisuga T., Kawarabayashi T. Histopathological analysis of laparoscopically treated ovarian endometriotic cysts with special reference to loss of follicles // Hum Reprod. 2002. Vol. 17, N 2. P. 432–435. doi: 10.1093/humrep/17.2.432

[9] Hachisuga T, Kawarabayashi T. Histopathological analysis of laparoscopically treated ovarian endometriotic cysts with special reference to loss of follicles. Hum Reprod. 2002;17(2):432–435. doi: 10.1093/humrep/17.2.432

[10] Somigliana E, Berlanda N, Benaglia L, et al. Surgical excision of endometriomas and ovarian reserve: a systematic review on serum antimüllerian hormone level modifications. Fertil Steril. 2012;98(6):1531–1538. doi: 10.1016/j.fertnstert.2012.08.009

[11] Somigliana E., Berlanda N., Benaglia L., et al. Surgical excision of endometriomas and ovarian reserve: a systematic review on serum antimüllerian hormone level modifications // Fertil Steril. 2012. Vol. 98, N 6. P. 1531–1538. doi: 10.1016/j.fertnstert.2012.08.009

[12] Somigliana E, Berlanda N, Benaglia L, et al. Surgical excision of endometriomas and ovarian reserve: a systematic review on serum antimüllerian hormone level modifications. Fertil Steril. 2012;98(6):1531–1538. doi: 10.1016/j.fertnstert.2012.08.009

[13] Alborzi S, Keramati P, Younesi M, et al. The impact of laparoscopic cystectomy on ovarian reserve in patients with unilateral and bilateral endometriomas. Fertil Steril. 2014;101(2):427–434. doi: 10.1016/j.fertnstert.2013.10.019

[14] Alborzi S., Keramati P., Younesi M., et al. The impact of laparoscopic cystectomy on ovarian reserve in patients with unilateral and bilateral endometriomas // Fertil Steril. 2014. Vol. 101, N 2. P. 427–434. doi: 10.1016/j.fertnstert.2013.10.019

[15] Alborzi S, Keramati P, Younesi M, et al. The impact of laparoscopic cystectomy on ovarian reserve in patients with unilateral and bilateral endometriomas. Fertil Steril. 2014;101(2):427–434. doi: 10.1016/j.fertnstert.2013.10.019

[16] Raffi F, Metwally M, Amer S. The impact of excision of ovarian endometrioma on ovarian reserve: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2012;97(9):3146–3154. doi: 10.1210/jc.2012-1558

[17] Raffi F., Metwally M., Amer S. The impact of excision of ovarian endometrioma on ovarian reserve: a systematic review and meta-analysis // J Clin Endocrinol Metab. 2012. Vol. 97, N 9. P. 3146–3154. doi: 10.1210/jc.2012-1558

[18] Raffi F, Metwally M, Amer S. The impact of excision of ovarian endometrioma on ovarian reserve: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2012;97(9):3146–3154. doi: 10.1210/jc.2012-1558

[19] Muzii L, Achilli C, Lecce F, et al. Second surgery for recurrent endometriomas is more harmful to healthy ovarian tissue and ovarian reserve than first surgery. Fertil Steril. 2015;103(3):738–743. doi: 10.1016/j.fertnstert.2014.12.101

[20] Muzii L., Achilli C., Lecce F., et al. Second surgery for recurrent endometriomas is more harmful to healthy ovarian tissue and ovarian reserve than first surgery // Fertil Steril. 2015. Vol. 103, N 3. P. 738–743. doi: 10.1016/j.fertnstert.2014.12.101

[21] Muzii L, Achilli C, Lecce F, et al. Second surgery for recurrent endometriomas is more harmful to healthy ovarian tissue and ovarian reserve than first surgery. Fertil Steril. 2015;103(3):738–743. doi: 10.1016/j.fertnstert.2014.12.101

[22] Dunselman GA, Vermeulen N, Becker C, et al. ESHRE guideline: management of women with endometriosis. Hum Reprod. 2014;29(3):400–412. doi: 10.1093/humrep/det457

[23] Dunselman G.A., Vermeulen N., Becker C., et al. ESHRE guideline: management of women with endometriosis // Hum Reprod. 2014. Vol. 29, N 3. P. 400–412. doi: 10.1093/humrep/det457

[24] Dunselman GA, Vermeulen N, Becker C, et al. ESHRE guideline: management of women with endometriosis. Hum Reprod. 2014;29(3):400–412. doi: 10.1093/humrep/det457

[25] Alshehre SM, Narice BF, Fenwick MA, Metwally M. The impact of endometrioma on in vitro fertilisation/intra-cytoplasmic injection IVF/ICSI reproductive outcomes: a systematic review and meta-analysis. Arch Gynecol Obstet. 2021;303(1):3–16. doi: 10.1007/s00404-020-05796-9

[26] Alshehre S.M., Narice B.F., Fenwick M.A., Metwally M. The impact of endometrioma on in vitro fertilisation/intra-cytoplasmic injection IVF/ICSI reproductive outcomes: a systematic review and meta-analysis // Arch Gynecol Obstet. 2021. Vol. 303, N 1. P. 3–16. doi: 10.1007/s00404-020-05796-9

[27] Alshehre SM, Narice BF, Fenwick MA, Metwally M. The impact of endometrioma on in vitro fertilisation/intra-cytoplasmic injection IVF/ICSI reproductive outcomes: a systematic review and meta-analysis. Arch Gynecol Obstet. 2021;303(1):3–16. doi: 10.1007/s00404-020-05796-9

[28] Coccia ME, Rizzello F, Barone S, et al. Is there a critical endometrioma size associated with reduced ovarian responsiveness in assisted reproduction techniques? Reprod Biomed Online. 2014;29(2):259–266. doi: 10.1016/j.rbmo.2014.04.019

[29] Coccia M.E., Rizzello F., Barone S., et al. Is there a critical endometrioma size associated with reduced ovarian responsiveness in assisted reproduction techniques? // Reprod Biomed Online. 2014. Vol. 29, N 2. P. 259–266. doi: 10.1016/j.rbmo.2014.04.019

[30] Coccia ME, Rizzello F, Barone S, et al. Is there a critical endometrioma size associated with reduced ovarian responsiveness in assisted reproduction techniques? Reprod Biomed Online. 2014;29(2):259–266. doi: 10.1016/j.rbmo.2014.04.019

[31] Benaglia L, Busnelli A, Biancardi R, et al. Oocyte retrieval difficulties in women with ovarian endometriomas. Reprod Biomed Online. 2018;37(1):77–84. doi: 10.1016/j.rbmo.2018.03.020

[32] Benaglia L., Busnelli A., Biancardi R., et al. Oocyte retrieval difficulties in women with ovarian endometriomas // Reprod Biomed Online. 2018. Vol. 37, N 1. P. 77–84. doi: 10.1016/j.rbmo.2018.03.020

[33] Benaglia L, Busnelli A, Biancardi R, et al. Oocyte retrieval difficulties in women with ovarian endometriomas. Reprod Biomed Online. 2018;37(1):77–84. doi: 10.1016/j.rbmo.2018.03.020

[34] Akamatsu N, Hirai T, Masaoka H, et al. Ultrasonically guided puncture of endometrial cysts-aspiration of contents and infusion of ethanol. Nihon Sanka Fujinka Gakkai Zasshi. 1988;40(2):187–191.

[35] Akamatsu N., Hirai T., Masaoka H., et al. Ultrasonically guided puncture of endometrial cysts-aspiration of contents and infusion of ethanol // Nihon Sanka Fujinka Gakkai Zasshi. 1988. Vol. 40, N 2. P. 187–191.

[36] Akamatsu N, Hirai T, Masaoka H, et al. Ultrasonically guided puncture of endometrial cysts-aspiration of contents and infusion of ethanol. Nihon Sanka Fujinka Gakkai Zasshi. 1988;40(2):187–191.

[37] Albanese G, Kondo KL. Pharmacology of sclerotherapy. Semin Intervent Radiol. 2010;27(4):391–399. doi: 10.1055/s-0030-1267848

[38] Albanese G., Kondo K.L. Pharmacology of sclerotherapy // Semin Intervent Radiol. 2010. Vol. 27, N 4. P. 391–399. doi: 10.1055/s-0030-1267848

[39] Albanese G, Kondo KL. Pharmacology of sclerotherapy. Semin Intervent Radiol. 2010;27(4):391–399. doi: 10.1055/s-0030-1267848

[40] Hsieh CL, Shiau CS, Lo LM, et al. Effectiveness of ultrasound-guided aspiration and sclerotherapy with 95% ethanol for treatment of recurrent ovarian endometriomas. Fertil Steril. 2009;91(6):2709–2713. doi: 10.1016/j.fertnstert.2008.03.056

[41] Hsieh C.L., Shiau C.S., Lo L.M., et al. Effectiveness of ultrasound-guided aspiration and sclerotherapy with 95% ethanol for treatment of recurrent ovarian endometriomas // Fertil Steril. 2009. Vol. 91, N 6. P. 2709–2713. doi: 10.1016/j.fertnstert.2008.03.056

[42] Hsieh CL, Shiau CS, Lo LM, et al. Effectiveness of ultrasound-guided aspiration and sclerotherapy with 95% ethanol for treatment of recurrent ovarian endometriomas. Fertil Steril. 2009;91(6):2709–2713. doi: 10.1016/j.fertnstert.2008.03.056

[43] Vaduva CC, Dira L, Carp-Veliscu A, et al. Ovarian reserve after treatment of ovarian endometriomas by ethanolic sclerotherapy compared to surgical treatment. Eur Rev Med Pharmacol Sci. 2023;27(12):5575–5582. doi: 10.26355/eurrev_202306_32795

[44] Vaduva C.C., Dira L., Carp-Veliscu A., et al. Ovarian reserve after treatment of ovarian endometriomas by ethanolic sclerotherapy compared to surgical treatment // Eur Rev Med Pharmacol Sci. 2023. Vol. 27, N 12. P. 5575–5582. doi: 10.26355/eurrev_202306_32795

[45] Vaduva CC, Dira L, Carp-Veliscu A, et al. Ovarian reserve after treatment of ovarian endometriomas by ethanolic sclerotherapy compared to surgical treatment. Eur Rev Med Pharmacol Sci. 2023;27(12):5575–5582. doi: 10.26355/eurrev_202306_32795

[46] Martinez-Garcia JM, Candas B, Suarez-Salvador E, et al. Comparing the effects of alcohol sclerotherapy with those of surgery on anti-Müllerian hormone and ovarian reserve after endometrioma treatment. A prospective multicenter pilot cohort study. Eur J Obstet Gynecol Reprod Biol. 2021;259:60–66. doi: 10.1016/j.ejogrb.2021.01.027

[47] Martinez-Garcia J.M., Candas B., Suarez-Salvador E., et al. Comparing the effects of alcohol sclerotherapy with those of surgery on anti-Müllerian hormone and ovarian reserve after endometrioma treatment. A prospective multicenter pilot cohort study // Eur J Obstet Gynecol Reprod Biol. 2021. Vol. 259. P. 60–66. doi: 10.1016/j.ejogrb.2021.01.027

[48] Martinez-Garcia JM, Candas B, Suarez-Salvador E, et al. Comparing the effects of alcohol sclerotherapy with those of surgery on anti-Müllerian hormone and ovarian reserve after endometrioma treatment. A prospective multicenter pilot cohort study. Eur J Obstet Gynecol Reprod Biol. 2021;259:60–66. doi: 10.1016/j.ejogrb.2021.01.027

[49] Yazbeck C, Koskas M, Cohen Scali S, et al. Comment je fais… la sclérothérapie à l'éthanol d'un endométriome [How I do... ethanol sclerotherapy for ovarian endometriomas]. Gynecol Obstet Fertil. 2012;40(10):620–622. doi: 10.1016/j.gyobfe.2012.07.029

[50] Yazbeck C., Koskas M., Cohen Scali S., et al. Comment je fais… la sclérothérapie à l'éthanol d'un endométriome [How I do... ethanol sclerotherapy for ovarian endometriomas] // Gynecol Obstet Fertil. 2012. Vol. 40, N 10. P. 620–622. doi: 10.1016/j.gyobfe.2012.07.029

[51] Yazbeck C, Koskas M, Cohen Scali S, et al. Comment je fais… la sclérothérapie à l'éthanol d'un endométriome [How I do... ethanol sclerotherapy for ovarian endometriomas]. Gynecol Obstet Fertil. 2012;40(10):620–622. doi: 10.1016/j.gyobfe.2012.07.029

[52] Miquel L, Preaubert L, Gnisci A, et al. Transvaginal ethanol sclerotherapy for an endometrioma in 10 steps. Fertil Steril. 2021;115(1):259–260. doi: 10.1016/j.fertnstert.2020.08.1422

[53] Miquel L., Preaubert L., Gnisci A., et al. Transvaginal ethanol sclerotherapy for an endometrioma in 10 steps // Fertil Steril. 2021. Vol. 115, N 1. P. 259–260. doi: 10.1016/j.fertnstert.2020.08.1422

[54] Miquel L, Preaubert L, Gnisci A, et al. Transvaginal ethanol sclerotherapy for an endometrioma in 10 steps. Fertil Steril. 2021;115(1):259–260. doi: 10.1016/j.fertnstert.2020.08.1422

[55] Miquel L, Preaubert L, Gnisci A, et al. Endometrioma ethanol sclerotherapy could increase IVF live birth rate in women with moderate-severe endometriosis. PLoS One. 2020;15(9):e0239846. doi: 10.1371/journal.pone.0239846

[56] Miquel L., Preaubert L., Gnisci A., et al. Endometrioma ethanol sclerotherapy could increase IVF live birth rate in women with moderate-severe endometriosis // PLoS One. 2020. Vol. 15, N 9. P. e0239846. doi: 10.1371/journal.pone.0239846

[57] Miquel L, Preaubert L, Gnisci A, et al. Endometrioma ethanol sclerotherapy could increase IVF live birth rate in women with moderate-severe endometriosis. PLoS One. 2020;15(9):e0239846. doi: 10.1371/journal.pone.0239846

[58] Alborzi S, Zahiri Sorouri Z, Askari E, et al. The success of various endometrioma treatments in infertility: A systematic review and meta-analysis of prospective studies. Reprod Med Biol. 2019;18(4):312–322. doi: 10.1002/rmb2.12286

[59] Alborzi S., Zahiri Sorouri Z., Askari E., et al. The success of various endometrioma treatments in infertility: A systematic review and meta-analysis of prospective studies // Reprod Med Biol. 2019. Vol. 18, N 4. P. 312–322. doi: 10.1002/rmb2.12286

[60] Alborzi S, Zahiri Sorouri Z, Askari E, et al. The success of various endometrioma treatments in infertility: A systematic review and meta-analysis of prospective studies. Reprod Med Biol. 2019;18(4):312–322. doi: 10.1002/rmb2.12286

[61] Cohen A, Almog B, Tulandi T. Sclerotherapy in the management of ovarian endometrioma: systematic review and meta-analysis. Fertil Steril. 2017;108(1):117–124. doi: 10.1016/j.fertnstert.2017.05.015

[62] Cohen A., Almog B., Tulandi T. Sclerotherapy in the management of ovarian endometrioma: systematic review and meta-analysis // Fertil Steril. 2017. Vol. 108, N 1. P. 117–124. doi: 10.1016/j.fertnstert.2017.05.015

[63] Cohen A, Almog B, Tulandi T. Sclerotherapy in the management of ovarian endometrioma: systematic review and meta-analysis. Fertil Steril. 2017;108(1):117–124. doi: 10.1016/j.fertnstert.2017.05.015

[64] Yazbeck C, Madelenat P, Ayel JP, et al. Ethanol sclerotherapy: a treatment option for ovarian endometriomas before ovarian stimulation. Reprod Biomed Online. 2009;19(1):121–125. doi: 10.1016/s1472-6483(10)60055-7

[65] Yazbeck C., Madelenat P., Ayel J.P., et al. Ethanol sclerotherapy: a treatment option for ovarian endometriomas before ovarian stimulation // Reprod Biomed Online. 2009. Vol. 19, N 1. P. 121–125. doi: 10.1016/s1472-6483(10)60055-7

[66] Yazbeck C, Madelenat P, Ayel JP, et al. Ethanol sclerotherapy: a treatment option for ovarian endometriomas before ovarian stimulation. Reprod Biomed Online. 2009;19(1):121–125. doi: 10.1016/s1472-6483(10)60055-7

[67] Garcia-Tejedor A, Martinez-Garcia JM, Candas B, et al. Ethanol sclerotherapy versus laparoscopic surgery for endometrioma treatment: a prospective, multicenter, cohort pilot study. J Minim Invasive Gynecol. 2020;27(5):1133–1140. doi: 10.1016/j.jmig.2019.08.036

[68] Garcia-Tejedor A., Martinez-Garcia J.M., Candas B., et al. Ethanol sclerotherapy versus laparoscopic surgery for endometrioma treatment: a prospective, multicenter, cohort pilot study // J Minim Invasive Gynecol. 2020. Vol. 27, N 5. P. 1133–1140. doi: 10.1016/j.jmig.2019.08.036

[69] Garcia-Tejedor A, Martinez-Garcia JM, Candas B, et al. Ethanol sclerotherapy versus laparoscopic surgery for endometrioma treatment: a prospective, multicenter, cohort pilot study. J Minim Invasive Gynecol. 2020;27(5):1133–1140. doi: 10.1016/j.jmig.2019.08.036

[70] Noma J, Yoshida N. Efficacy of ethanol sclerotherapy for ovarian endometriomas. Int J Gynaecol Obstet. 2001;72(1):35–39. doi: 10.1016/s0020-7292(00)00307-6

[71] Noma J., Yoshida N. Efficacy of ethanol sclerotherapy for ovarian endometriomas // Int J Gynaecol Obstet. 2001. Vol. 72, N 1. P. 35–39. doi: 10.1016/s0020-7292(00)00307-6

[72] Noma J, Yoshida N. Efficacy of ethanol sclerotherapy for ovarian endometriomas. Int J Gynaecol Obstet. 2001;72(1):35–39. doi: 10.1016/s0020-7292(00)00307-6

[73] Haraguchi H, Koga K, Takamura M, et al. Development of ovarian cancer after excision of endometrioma. Fertil Steril. 2016;106(6):1432–1437. doi: 10.1016/j.fertnstert.2016.07.1077

[74] Haraguchi H., Koga K., Takamura M., et al. Development of ovarian cancer after excision of endometrioma // Fertil Steril. 2016. Vol. 106, N 6. P. 1432–1437. doi: 10.1016/j.fertnstert.2016.07.1077

[75] Haraguchi H, Koga K, Takamura M, et al. Development of ovarian cancer after excision of endometrioma. Fertil Steril. 2016;106(6):1432–1437. doi: 10.1016/j.fertnstert.2016.07.1077

[76] Sasamoto N, DePari M, Vitonis AF, et al. Evaluation of CA125 in relation to pain symptoms among adolescents and young adult women with and without surgically-confirmed endometriosis. PLoS One. 2020;15(8):e0238043. doi: 10.1371/journal.pone.0238043

[77] Sasamoto N., DePari M., Vitonis A.F., et al. Evaluation of CA125 in relation to pain symptoms among adolescents and young adult women with and without surgically-confirmed endometriosis // PLoS One. 2020. Vol. 15, N 8. P. e0238043. doi: 10.1371/journal.pone.0238043

[78] Sasamoto N, DePari M, Vitonis AF, et al. Evaluation of CA125 in relation to pain symptoms among adolescents and young adult women with and without surgically-confirmed endometriosis. PLoS One. 2020;15(8):e0238043. doi: 10.1371/journal.pone.0238043

[79] Kvaskoff M, Mahamat-Saleh Y, Farland LV, et al. Endometriosis and cancer: a systematic review and meta-analysis. Hum Reprod Update. 2021;27(2):393–420. doi: 10.1093/humupd/dmaa045

[80] Kvaskoff M., Mahamat-Saleh Y., Farland L.V., et al. Endometriosis and cancer: a systematic review and meta-analysis // Hum Reprod Update. 2021. Vol. 27, N 2. P. 393–420. doi: 10.1093/humupd/dmaa045

[81] Kvaskoff M, Mahamat-Saleh Y, Farland LV, et al. Endometriosis and cancer: a systematic review and meta-analysis. Hum Reprod Update. 2021;27(2):393–420. doi: 10.1093/humupd/dmaa045

[82] Mais V, Guerriero S, Ajossa S, et al. The efficiency of transvaginal ultrasonography in the diagnosis of endometrioma. Fertil Steril. 1993;60(5):776–780. doi: 10.1016/s0015-0282(16)56275-x

[83] Mais V., Guerriero S., Ajossa S., et al. The efficiency of transvaginal ultrasonography in the diagnosis of endometrioma // Fertil Steril. 1993. Vol. 60, N 5. P. 776–780. doi: 10.1016/s0015-0282(16)56275-x

[84] Mais V, Guerriero S, Ajossa S, et al. The efficiency of transvaginal ultrasonography in the diagnosis of endometrioma. Fertil Steril. 1993;60(5):776–780. doi: 10.1016/s0015-0282(16)56275-x

RIGHTS & PERMISSIONS

Eco-Vector